Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob I Stuckey

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
ACS Chemical Biology|June 30, 2016
Chromodomain Ligand Optimization via Target-Class Directed Combinatorial RepurposingKimberly D Barnash, Kelsey N Lamb, Jacob I Stuckey, et al.
Journal of Medicinal Chemistry|August 30, 2016
Structure-Activity Relationships and Kinetic Studies of Peptidic Antagonists of CBX ChromodomainsJacob I Stuckey, Catherine Simpson, Jacqueline L Norris-Drouin, et al.
Nature Communications|May 1, 2019
Canonical PRC1 controls sequence-independent propagation of Polycomb-mediated gene silencingHagar F Moussa, Daniel Bsteh, Ramesh Yelagandula, et al.
ACS Combinatorial Science|February 7, 2017
Discovery of Peptidomimetic Ligands of EED as Allosteric Inhibitors of PRC2Kimberly D Barnash, Juliana The, Jacqueline L Norris-Drouin, et al.
The Journal of Biological Chemistry|February 1, 2021
Identification and characterization of second-generation EZH2 inhibitors with extended residence times and improved biological activityJacob I Stuckey, Nico R Cantone, Alexandre Côté, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Design, Synthesis, and Pharmacological Evaluation of Second Generation EZH2 Inhibitors with Long Residence TimeAvinash Khanna, Alexandre Côté, Shilpi Arora, et al.
Cell Chemical Biology|May 28, 2026
Covalent PPARγ inverse agonism by FX-909 reveals mechanistic insights into therapeutic targeting of PPARγ/RXRα-activated urothelial carcinomaJacob I Stuckey, Jennifer A Mertz, Jonathan E Wilson, et al.
Biochemistry|November 29, 2018
Correction to "Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID subunit 1"Junghyun L Suh, Brian Watts, Jacob I Stuckey, et al.
Biochemistry|March 21, 2018
Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID Subunit 1Junghyun L Suh, Brian Watts, Jacob I Stuckey, et al.
Cell Chemical Biology|August 20, 2019
Discovery and Characterization of a Cellular Potent Positive Allosteric Modulator of the Polycomb Repressive Complex 1 Chromodomain, CBX7Kelsey N Lamb, Daniel Bsteh, Sarah N Dishman, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
ACS Chemical Biology|June 30, 2016
Chromodomain Ligand Optimization via Target-Class Directed Combinatorial RepurposingKimberly D Barnash, Kelsey N Lamb, Jacob I Stuckey, et al.
Journal of Medicinal Chemistry|August 30, 2016
Structure-Activity Relationships and Kinetic Studies of Peptidic Antagonists of CBX ChromodomainsJacob I Stuckey, Catherine Simpson, Jacqueline L Norris-Drouin, et al.
Nature Communications|May 1, 2019
Canonical PRC1 controls sequence-independent propagation of Polycomb-mediated gene silencingHagar F Moussa, Daniel Bsteh, Ramesh Yelagandula, et al.
ACS Combinatorial Science|February 7, 2017
Discovery of Peptidomimetic Ligands of EED as Allosteric Inhibitors of PRC2Kimberly D Barnash, Juliana The, Jacqueline L Norris-Drouin, et al.
The Journal of Biological Chemistry|February 1, 2021
Identification and characterization of second-generation EZH2 inhibitors with extended residence times and improved biological activityJacob I Stuckey, Nico R Cantone, Alexandre Côté, et al.
ACS Medicinal Chemistry Letters|June 20, 2020
Design, Synthesis, and Pharmacological Evaluation of Second Generation EZH2 Inhibitors with Long Residence TimeAvinash Khanna, Alexandre Côté, Shilpi Arora, et al.
Cell Chemical Biology|May 28, 2026
Covalent PPARγ inverse agonism by FX-909 reveals mechanistic insights into therapeutic targeting of PPARγ/RXRα-activated urothelial carcinomaJacob I Stuckey, Jennifer A Mertz, Jonathan E Wilson, et al.
Biochemistry|November 29, 2018
Correction to "Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID subunit 1"Junghyun L Suh, Brian Watts, Jacob I Stuckey, et al.
Biochemistry|March 21, 2018
Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID Subunit 1Junghyun L Suh, Brian Watts, Jacob I Stuckey, et al.
Cell Chemical Biology|August 20, 2019
Discovery and Characterization of a Cellular Potent Positive Allosteric Modulator of the Polycomb Repressive Complex 1 Chromodomain, CBX7Kelsey N Lamb, Daniel Bsteh, Sarah N Dishman, et al.
Pageof 2